Brian Aalbers
Neurology with Special Qualifications in Child Neurology · Kansas City, MONPI 1740584747
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Aquestive Therapeutics, Inc. at 41.7% of the total. Reporting peaked in 2019 at $3,681 and has fallen 81.8% since, to $671 in 2023.
Across 154 payments — averaging $41.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aquestive Therapeutics, Inc.$3K
- Medtronic$984
- Jazz Pharmaceuticals Inc.$518
- UCB, Inc.$336
- Neurocrine Biosciences, Inc.$270
- Teva Pharmaceuticals USA, Inc.$167
- plus $1K from 32 others
What the payments were for
- Consulting fees$2,67542%
- Travel & lodging$68411%
- Food & beverage$2,80444%
- Education$1863%
- Gifts$661%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aquestive Therapeutics, Inc. | 2 | $2,675 |
| Medtronic(2 entities) | 12 | $984 |
| Jazz Pharmaceuticals Inc. | 20 | $518 |
| UCB, Inc. | 17 | $336 |
| Neurocrine Biosciences, Inc. | 12 | $270 |
| Teva Pharmaceuticals USA, Inc. | 8 | $167 |
| Amgen | 8 | $153 |
| Saol Therapeutics Inc. | 6 | $135 |
| Supernus Pharmaceuticals, Inc. | 9 | $129 |
| AbbVie(2 entities) | 6 | $107 |
| Piramal Critical Care | 2 | $100 |
| Sunovion Pharmaceuticals Inc. | 6 | $77 |
| Ipsen Biopharmaceuticals, Inc | 3 | $59 |
| Intuitive Surgical | 1 | $54 |
| SK Life Science, Inc. | 3 | $53 |
| Travere Therapeutics, Inc. | 10 | $51 |
| Impel Pharmaceuticals Inc. | 3 | $49 |
| Neurelis, Inc. | 2 | $46 |
| Abbott | 2 | $42 |
| Tersera Therapeutics LLC | 2 | $38 |
| Harmony Biosciences LLC | 2 | $37 |
| Nevro Corp. | 1 | $30 |
| Sanofi | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Livanova USA, Inc. | 1 | $24 |
| Greenwich Biosciences, Inc. | 1 | $24 |
| Zyla Life Sciences, Inc. | 2 | $24 |
| Mallinckrodt Enterprises LLC | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| GRT US Holding, Inc. | 1 | $17 |
| Biogen | 1 | $16 |
| Novartis | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| GE HealthCare | 1 | $14 |
| Lundbeck LLC | 1 | $13 |
| Aprecia Pharmaceuticals, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYMPAZAN$2,675
- PERCEPT PC BRAINSENSE$533
How this compares
$6,416 in reported general payments places this provider in the 85th percentile of 41 neurology with special qualifications in child neurology providers in Missouri.
See all neurology with special qualifications in child neurology providers in Missouri →
Other neurology with special qualifications in child neurology in Kansas City
- Ahmed AbdelmoityKansas City$1.1M
- Mirza Waseem BaigKansas City$3K
- Lalit BansalKansas City$2K
- Kailash PawarKansas City$402
- Roha KhalidKansas City$327
- Miriam Baltuano SonghurstKansas City$260
- Marcie FilesKansas City$209
- Lines Vargas ColladoKansas City$180
- Jaclyn PerainoKansas City$122
- Mark GradyKansas City$84
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.